We found for
Cornerstones of “Fair” Drug Coverage: Appropriate Cost – Sharing and Utilization Management Policies for Pharmaceuticals
![Cornerstones of “Fair” Drug Coverage: Appropriate Cost - Sharing and Utilization Management Policies for Pharmaceuticals](https://www.ohe.org/wp-content/uploads/2020/09/Font-Cover.jpg)
Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates
![Value, Access, and Incentives for Innovation - Policy Perspectives on Alternative Models for Pharmaceutical Rebates](https://www.ohe.org/wp-content/uploads/2019/03/Value-Access-and-Incentives-for-Innovation-Policy-Perspectives-on-Alternative-Models-for-Pharmaceutical-Rebates.jpg)
Understanding the Context, Selecting the Standards: A Framework to Guide the Optimal Development and Use of Real-World Evidence for Coverage and Formulary Decisions
![Understanding the Context Cover Page](https://www.ohe.org/wp-content/uploads/2018/04/Understanding-the-Context-Cover-Page_1.jpg)
Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies
![2016](https://www.ohe.org/wp-content/uploads/2017/04/2016.jpg)
HTA and Decision Making in Asia: How can the available resources be used most effectively to deliver high quality HTA that can be used by health system decision makers?
![HTA and decision making in asia cover page](https://www.ohe.org/wp-content/uploads/2018/03/HTA-and-decision-making-in-asia-cover-page.jpg)